Short answer
- MRSA stands for methicillin-resistant Staphylococcus aureus. It is a type of Staphylococcus aureus, a very common bacterium, that is resistant to several antibiotics.
- About one in three people carry Staphylococcus aureus on their skin or in their nose without any illness, according to the US Centers for Disease Control and Prevention (CDC). About two in 100 people carry MRSA specifically, and most of them do not develop a serious infection.
- Resistance comes mainly from an acquired gene called mecA, which produces an altered cell wall building protein, PBP2a, that beta-lactam antibiotics bind poorly. That is why penicillins and related antibiotics often cannot stop MRSA.
- MRSA is grouped by setting into healthcare-associated, community-associated, and livestock-associated types, but these are descriptive labels, and the groups overlap.
- MRSA spreads mainly through direct contact with an infected person or wound, through contaminated hands, or through objects that have touched infected skin. It can survive on some surfaces for hours, days, or even weeks.
- MRSA matters because infections can be harder to treat and, if left untreated, can lead to bloodstream infection, pneumonia, surgical site infection, sepsis, or death. The CDC lists MRSA as a serious threat, and WHO lists it as a high priority pathogen.
What Is Staphylococcus Aureus?
Staphylococcus aureus, often shortened to S. aureus and commonly called staph, is a round bacterium that grows in clusters. It is one of the most common bacteria that live on and in the human body. The CDC states that about one out of every three people carry the germ on their skin or in their nose, and that it does not cause problems for most people.
That quiet presence has a name: colonization. Colonization means bacteria are present on the skin or in the nose without causing illness. A person who is colonized is sometimes called a carrier. Carrying S. aureus is normal for a large share of the population, and it is not, on its own, a sign of disease. Problems begin when the bacteria get past the body’s outer defenses, for example through a cut, scrape, surgical wound, or medical device site.
S. aureus can cause a wide range of infections. The most common are skin and soft tissue infections, which appear as a bump or infected area on the skin. More serious infections can affect the bloodstream, the lungs, bones and joints, the heart, and surgical wounds. People with weakened immune defenses, people recovering from surgery, and people with long term medical devices tend to face higher risk, but healthy people can also develop staph infections.
It helps to separate two ideas that are often confused. First, S. aureus is the species, the bacterium itself. Second, MRSA and MSSA are labels for strains within that species, based on whether they resist methicillin and related antibiotics. MSSA stands for methicillin-susceptible Staphylococcus aureus, meaning strains that beta-lactam antibiotics can still stop. MRSA strains cannot be stopped by those drugs. The distinction is about drug resistance, not about a different species.
What Does Methicillin Resistance Mean?
Methicillin was an antibiotic developed to treat staph infections that had already become resistant to penicillin. It belongs to a large family of antibiotics called beta-lactams, which also includes penicillins, cephalosporins, and carbapenems. Beta-lactam antibiotics work by binding to proteins that bacteria use to build their cell walls. These proteins are called penicillin-binding proteins. When the drugs bind to them, the bacterium cannot finish building its wall properly, and the cell is damaged.
MRSA escapes this attack through a genetic change. Most MRSA strains carry an acquired gene called mecA. The mecA gene sits on a mobile genetic element called the staphylococcal cassette chromosome mec, usually shortened to SCCmec, which can move between staphylococcal bacteria. The mecA gene produces an altered penicillin-binding protein called PBP2a. PBP2a has very low affinity for beta-lactam antibiotics, which means the drugs bind to it poorly. While the bacterium’s normal penicillin-binding proteins are blocked by the antibiotic, PBP2a keeps building the cell wall, so the bacterium survives and keeps growing.
A rarer related gene, mecC, can produce a similar altered protein, PBP2c, and cause the same kind of resistance. It is much less common than mecA.
Two points are often misunderstood. First, resistance is not the same as invulnerability. MRSA is resistant to several antibiotics, but the CDC notes that there are antibiotics available to treat MRSA infections, and that a healthcare provider determines which treatment fits a given case. Resistance narrows the options; it does not remove all of them. Second, resistance is not something a person’s body develops. It is a property of the bacterium, carried in its genes.
The name MRSA is now partly historical. Methicillin is no longer used in clinical practice. The term methicillin-resistant remains in use because it marks resistance to the whole beta-lactam group in laboratory testing.
A Brief History of MRSA
MRSA was first isolated in 1961 in the United Kingdom, one year after methicillin was introduced into clinical practice. The speed of that appearance is a central lesson in antibiotic resistance: once a new antibiotic is widely used, resistant strains can emerge quickly, because any bacterium carrying a protective gene survives while susceptible bacteria die.
Through the 1960s and 1970s, MRSA remained mainly a hospital problem, appearing in outbreaks in healthcare facilities in Western Europe, Australia, and later the United States. Hospital strains of that era were often resistant to several antibiotic groups at once, which made outbreaks difficult to control.
A shift came in the 1980s and 1990s, when reports of MRSA infections in people with no recent hospital contact began to appear. These community-associated infections were first described in the early 1980s, including a large outbreak among people who inject drugs in Detroit, Michigan. Through the 1990s, community-associated MRSA spread more widely, including among children and people in close contact settings such as sports teams.
Livestock-associated MRSA was recognized later. In 2004, MRSA was first isolated on a pig farm in the Netherlands, which led to wider investigation of MRSA in farm animals and in people who work closely with livestock, adding a third setting to the picture.
How MRSA Is Classified
MRSA is usually described in three broad groups, based on where the infection appears to have been acquired. These labels describe setting and context, not different species, and the boundaries between them have blurred as strains have moved between settings.
Healthcare-associated MRSA, shortened to HA-MRSA, refers to infections linked to healthcare settings such as hospitals and nursing homes, or to people with recent hospitalization, surgery, long term care residence, or invasive medical devices. These infections often occur in people who are already ill or recovering from a procedure, and the strains involved are frequently resistant to several antibiotic groups.
Community-associated MRSA, shortened to CA-MRSA, refers to infections in people with no recent healthcare contact, often in otherwise healthy people. These infections have been linked to skin to skin contact, shared equipment or personal items, crowded living conditions, and activities where skin gets cut or rubbed, such as contact sports. Community-associated strains have historically been resistant to fewer antibiotic groups than older hospital strains, but that distinction is not a rule, and it should not be used to judge how serious an individual infection is.
Livestock-associated MRSA, shortened to LA-MRSA, refers to strains linked to farm animals, especially pigs, and to people who work with them. Livestock-associated strains can colonize people who have close animal contact, and they can cause infections in those people. They are less common as a cause of infection in the general population than the other two groups.
Public health agencies now often sort cases by timing and exposure rather than by strain name alone, distinguishing infections that begin in the community from infections that begin in a hospital, using the timing of the first positive test relative to admission. Readers should therefore treat HA-MRSA, CA-MRSA, and LA-MRSA as useful shorthand for context, not as strict biological categories.
Where MRSA Is Found
MRSA lives in the same places S. aureus lives: on skin and in the nose, and on surfaces and objects that have been in contact with colonized or infected people. The CDC reports that about two in every 100 people carry MRSA, a figure that may be higher in certain populations. Most carriers do not develop serious infections. Carriage matters because a colonized person can pass the bacteria to others, and because their own risk of infection rises if the bacteria enter through broken skin or a medical device site.
Healthcare facilities are a major setting for MRSA because they bring together vulnerable patients, frequent skin breaks from surgery and devices, and many person to person contacts. Nursing homes and long term care facilities are also important settings, since residents often have wounds and devices. Prisons, military barracks, dormitories, gyms, locker rooms, and sports teams are community settings where close contact and shared items make spread easier. Crowded and unhygienic places raise risk in general, according to the CDC.
MRSA can also be found in the wider environment. The CDC notes that MRSA can survive on some surfaces, such as towels, razors, and furniture, for hours, days, or even weeks. That is why shared personal items and surfaces in gyms and locker rooms receive attention in prevention advice. Infection still normally requires the bacteria to reach broken skin or a vulnerable site.
Animals are part of the picture too. Pets such as dogs and cats can carry MRSA, usually after contact with colonized people, and livestock, especially pigs, carry livestock-associated strains. Human infections linked directly to pets are uncommon compared with person to person spread, and livestock-associated infections are concentrated among people with occupational animal contact.
How MRSA Spreads
In the community, MRSA spreads through contact with infected people, wounds, or things that have touched infected skin and are carrying the bacteria, according to the CDC: direct skin to skin contact, contact with drainage or pus from an infected wound, and contact with contaminated hands or shared objects.
In healthcare settings, the CDC clinical overview describes spread as usually happening through direct contact with an infected wound or through contaminated hands. Healthcare workers, visitors, and patients can all carry the bacteria on their hands from one person or surface to another. That is why hand hygiene is the most emphasized prevention step in healthcare guidance. People who carry MRSA without symptoms can also spread the bacteria to others, which is why hospitals use screening and precautions even for patients who feel well.
Broken skin is the usual doorway. The CDC notes that broken skin, such as scrapes or cuts, is often the site of a MRSA infection. A cut, an insect bite that has been scratched open, an ingrown hair, a tattoo or piercing site, or a surgical wound can all provide an entry point.
MRSA is not generally described as spreading through the air over long distances in the way that respiratory viruses do. It is a contact spread organism: it moves when skin, wounds, hands, or contaminated objects touch a new person or a new site. Close, repeated, skin to skin contact and shared personal items are.
What MRSA Infections Look Like in General Terms
The signs of a staph infection, including MRSA, depend on the part of the body that is infected. Most staph skin infections, including MRSA, appear as a bump or infected area on the skin that may be red, swollen, painful, warm to the touch, full of pus or other drainage, and sometimes accompanied by a fever, according to the CDC.
One important warning from the CDC is that you cannot tell by looking at the skin whether an infection is MRSA. A MRSA skin infection looks like other staph skin infections, and people sometimes mistake early MRSA skin infections for spider bites. The CDC notes that unless you actually see a spider, the irritation is likely not a spider bite. Only a laboratory test of a clinical specimen can determine whether MRSA is the cause of an infection.
Beyond the skin, MRSA can cause more serious infections. The CDC lists pneumonia, bloodstream infections, surgical site infections, and sepsis among the serious problems MRSA infections can cause in and outside healthcare settings, and notes that untreated MRSA infections can lead to death. Sepsis is the body’s extreme response to an infection. These serious forms are less common than skin infections, but they are the reason MRSA is treated as a public health priority rather than a minor skin problem.
Some groups face higher risk. The CDC notes that risk increases for people with hospitalizations or nursing home stays, people with skin to skin contact with others such as in contact sports, and people exposed to crowded and unhygienic places. The CDC clinical overview adds surgery, medical devices inserted in the body, and injecting drugs with needles as risk factors in healthcare settings. Risk factors raise probability; they do not determine any individual’s outcome.
Why Resistance Matters
Antibiotic resistance matters because it changes the odds in an infection. When first choice antibiotics fail, treatment takes longer, hospital stays lengthen, and the chance of complications rises. For MRSA, resistance to the beta-lactam group removes a large, well understood, and widely available family of drugs from the options. Clinicians must turn to other antibiotics, which may be less familiar or more expensive, and in some cases those options are also limited by additional resistance.
The scale of the problem in the United States is documented in the CDC 2019 Antibiotic Resistance Threats Report, which estimated 323,700 MRSA cases in hospitalized patients in 2017, with an estimated 10,600 deaths in that year. These are estimates for hospitalized patients in a single year, not a count of every MRSA infection, since many skin infections treated outside hospitals are not captured in that figure. The same report classifies MRSA among its serious threats.
Trends add context. CDC surveillance found that hospital-onset MRSA bloodstream infections fell by about 17 percent each year between 2005 and 2012, but that progress then slowed, with no significant change during 2013 to 2016. Community-onset MRSA bloodstream infections fell by about 7 percent each year between 2005 and 2016. The pattern shows that progress is possible, and also fragile.
Globally, WHO has placed MRSA on its list of high priority pathogens for research and development of new antibiotics, reflecting concern that resistant staph infections are widespread and that the pipeline of new drugs is thin. WHO also tracks MRSA through the Global Antimicrobial Resistance and Use Surveillance System, known as GLASS, which collects national data on the proportion of bloodstream infections caused by MRSA.
Resistance also matters beyond the individual patient. Every course of antibiotics creates selection pressure: susceptible bacteria die, and resistant survivors multiply. Slowing resistance is about using existing drugs carefully, preventing infections so antibiotics are needed less often, and tracking resistance so outbreaks are caught early.
Surveillance and Detection in General Terms
Tracking MRSA is a core public health activity. The CDC states that it tracks MRSA infections through the Emerging Infections Program and the National Healthcare Safety Network, and that data is also available through its Antimicrobial Resistance and Patient Safety Portal. The Emerging Infections Program uses population based surveillance in selected areas to estimate invasive MRSA infections and their trends, while the National Healthcare Safety Network collects data from healthcare facilities on infections in their care, letting facilities and health departments compare rates and spot outbreaks.
Detection starts with a clinical specimen. The CDC notes that a healthcare provider must send a clinical specimen to a laboratory to determine if MRSA is the cause of an infection. A sample from a wound, from blood, or from another infected site is grown in the laboratory and tested against a panel of antibiotics. The result shows which drugs the strain resists and which it remains susceptible to, and that result guides the provider’s decisions.
Screening is separate from diagnosis. In hospitals, screening means testing patients who have no symptoms, usually with a swab of the nose, to find out whether they carry MRSA. Screening helps hospitals apply precautions, such as gowns and gloves for staff contact and single room placement where available, to reduce spread to other patients. A positive screening result means colonization, not infection, and colonized patients usually do not need treatment for the carriage itself.
Molecular methods add detail for outbreak investigation and national surveillance. Tests that detect the mecA or mecC gene can confirm methicillin resistance quickly, and typing methods that compare the genetic fingerprints of strains can show whether infections in different patients or facilities are linked. These methods are mainly used by public health laboratories and for outbreak follow up, rather than for everyday diagnosis.
Prevention in General Terms
Prevention of MRSA rests on a small set of habits that reduce contact between the bacteria and vulnerable skin, and reduce the chance that bacteria on hands or objects reach another person. The CDC prevention guidance centers on hygiene, wound care, and not sharing personal items.
Hand and body hygiene come first. Cleaning hands often, and cleaning the body regularly, especially after exercise, reduces the bacteria present on skin and hands. In healthcare settings, hand hygiene before and after patient contact is the most important single step staff can take.
Wound care is the second pillar. The CDC advises keeping cuts and scrapes clean and covered with bandages or dressings until healed, following a healthcare provider’s instructions about proper wound care, and not picking at or popping a sore. Pus from infected wounds can contain MRSA, so used bandages should be thrown away with regular trash, and hands should be cleaned after handling them.
Not sharing personal items is the third pillar. Towels, washcloths, razors, and other items that touch skin should not be shared, because they can carry bacteria from one person to another even when they look clean. The CDC notes that even when a surface appears clean, it can still have germs.
In healthcare facilities, prevention also includes screening, contact precautions such as gowns and gloves, cleaning of rooms and equipment, and stewardship programs that promote careful antibiotic use. These facility measures work alongside the personal habits described above. No prevention step guarantees that infection will not occur, but together they lower the chance of spread in homes, gyms, schools, and hospitals.
Common Questions About MRSA
Is MRSA the same as a staph infection? MRSA is a type of staph infection, not a separate disease. All MRSA infections are staph infections, but not all staph infections are MRSA. The difference is drug resistance. If a staph strain can be stopped by beta-lactam antibiotics, it is MSSA. If it cannot, it is MRSA. The symptoms of a skin infection look the same either way.
Can MRSA be cured? In general terms, yes, MRSA infections can be treated. The CDC states that there are antibiotics available to treat MRSA infections, and that some types of staph infections need surgery to drain infected areas. Which option fits depends on the site and severity of the infection, and that decision belongs to a healthcare provider who has examined the patient and seen the laboratory results. This article does not describe treatment choices for any individual case.
Is MRSA contagious? MRSA can spread from person to person through contact, as described above, so in that sense it is contagious. But it is not as easily spread as a cold or flu virus, and casual contact such as being in the same room does not normally transmit it. Transmission normally needs skin contact, wound contact, contaminated hands, or shared items. A colonized person can spread MRSA without being ill, which is why hygiene and wound covering matter even when no one feels sick.
Do I need to worry about MRSA from pets or farm animals? For most people, person to person spread is the main concern. Pets can carry MRSA, and people who work closely with livestock can carry livestock-associated strains. If infections keep recurring in a household with a pet, a healthcare provider or veterinarian may advise checking the pet.
Why is MRSA called a superbug? Superbug is an informal term used in news coverage for bacteria that resist several antibiotics. It is not a scientific classification, and it can mislead, because it suggests the bacteria are unbeatable. MRSA is serious and harder to treat than susceptible staph, but it is not untreatable. Public health agencies prefer precise terms such as antibiotic resistant or methicillin-resistant, because they describe exactly which drugs fail.
Does having MRSA once mean you always have it? Colonization can persist for weeks or months, and it can clear on its own or recur. Some people carry MRSA repeatedly, especially if they have ongoing risk factors such as frequent healthcare contact or a household member who is colonized.
Frequently Asked Questions
What does MRSA stand for?
MRSA stands for methicillin-resistant Staphylococcus aureus: Staphylococcus aureus strains resistant to methicillin and related beta-lactam antibiotics, including penicillins, cephalosporins, and carbapenems.
How common is MRSA?
About two in every 100 people carry MRSA on their skin or in their nose, according to the CDC, and most carriers never develop a serious infection. About one in three people carry Staphylococcus aureus in general. MRSA infections are far less common than carriage, but they are common enough that the CDC tracks them nationally and lists MRSA as a serious threat.
What is the difference between MRSA and MSSA?
MSSA stands for methicillin-susceptible Staphylococcus aureus. MSSA strains can be stopped by beta-lactam antibiotics; MRSA strains cannot. The infections they cause look the same, and only a laboratory test can tell them apart.
How do you know if an infection is MRSA?
You cannot tell by looking. A skin infection caused by MRSA looks like other staph skin infections, and it is sometimes mistaken for a spider bite. Only a laboratory test of a clinical specimen can determine whether MRSA is the cause.
Where do people usually get MRSA?
MRSA is found in healthcare settings, in the community, and in livestock settings. Healthcare-associated infections are linked to hospitals, nursing homes, surgery, or medical devices. Community-associated infections occur in people without recent healthcare contact, often where there is skin to skin contact, shared items, or crowded conditions. Livestock-associated infections are linked to close contact with farm animals.
Can MRSA live on surfaces?
Yes. The CDC notes that MRSA can survive on some surfaces, such as towels, razors, and furniture, for hours, days, or even weeks. That is why personal items should not be shared and shared equipment should be cleaned.
What should I do if I notice a painful, red, swollen skin area?
This article gives general information only and is not medical advice. The CDC advises contacting a healthcare provider, especially if symptoms include a fever or do not improve within 48 hours, not picking at or popping the sore, covering the area with clean, dry bandages, and cleaning hands often.
Is MRSA a global problem?
Yes. MRSA occurs worldwide, and WHO lists it as a high priority pathogen. Countries track it through systems such as WHO GLASS and, in the United States, the CDC Emerging Infections Program and National Healthcare Safety Network. Resistance patterns vary by country and setting.
Why do antibiotics stop working against MRSA?
Because MRSA strains carry genes, most often mecA, that produce an altered cell wall protein, PBP2a, which beta-lactam antibiotics bind poorly. When those antibiotics cannot bind their target, they cannot stop the bacterium from building its wall.
Can MRSA be prevented?
Risk can be reduced, though not eliminated. The CDC steps are maintaining hand and body hygiene, not sharing personal items such as towels, washcloths, and razors, keeping cuts and scrapes clean and covered until healed, and not picking at sores. In healthcare facilities, screening, contact precautions, environmental cleaning, and careful antibiotic use add further protection.
Sources & references
- US Centers for Disease Control and Prevention, Methicillin-resistant Staphylococcus aureus (MRSA) Basics, updated June 26, 2025. https://www.cdc.gov/mrsa/about/index.html
- US Centers for Disease Control and Prevention, Clinical Overview of Methicillin-resistant Staphylococcus aureus (MRSA) in Healthcare Settings. https://www.cdc.gov/mrsa/hcp/clinical-overview/index.html
- US Centers for Disease Control and Prevention, Preventing Methicillin-resistant Staphylococcus aureus (MRSA). https://www.cdc.gov/mrsa/prevention/
- US Centers for Disease Control and Prevention, Antibiotic Resistance Threats Report 2019, MRSA fact sheet, estimated cases in hospitalized patients in 2017 and estimated deaths in 2017. https://stacks.cdc.gov/view/cdc/83741
- US Centers for Disease Control and Prevention, Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections, MMWR 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6421967/
- World Health Organization, Global Antimicrobial Resistance and Use Surveillance System (GLASS), bloodstream infection due to methicillin-resistant Staphylococcus aureus indicator. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/sdg-3.d.2-amr-infect-mrsa
- National Library of Medicine (PubMed Central), Staphylococcus aureus Infection: Pathogenesis and Antimicrobial Resistance, on the mecA gene, PBP2a, SCCmec, and mecC. https://pmc.ncbi.nlm.nih.gov/articles/PMC10179453/
- Journal of Clinical Investigation, The Staphylococcus aureus superbug, on mecA, PBP2a, and methicillin no longer being used clinically. https://www.jci.org/articles/view/23825
- Genome Research, Building a genomic framework for prospective MRSA surveillance in the United Kingdom and the Republic of Ireland, on MRSA first isolated in 1961, one year after methicillin entered clinical practice. https://genome.cshlp.org/content/26/2/263
